Patents by Inventor Michal RIVLIN

Michal RIVLIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucosamine and derivatives thereof in imaging
    Patent number: 10905783
    Abstract: Provided are formulations including a contrast agent selected from glucosamine, a salt thereof and a glucosamine derivative, for use in imaging.
    Type: Grant
    Filed: November 27, 2016
    Date of Patent: February 2, 2021
    Inventors: Michal Rivlin, Gil Navon
  • Glucose analogs for diagnosis states
    Patent number: 10736973
    Abstract: Provided are methods and formulations for imaging at least one body region of a subject, employing a glucose analog resistant or inactive to phosphrylation, or which is not a substrate for hexokinase.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: August 11, 2020
    Assignee: TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP
    Inventors: Gil Navon, Michal Rivlin, Ilan Tsarfaty
  • GLUCOSAMINE AND DERIVATIVES THEREOF IN IMAGING
    Publication number: 20180344879
    Abstract: Provided are formulations including a contrast agent selected from glucosamine, a salt thereof and a glucosamine derivative, for use in imaging.
    Type: Application
    Filed: November 27, 2016
    Publication date: December 6, 2018
    Inventors: Michal RIVLIN, Gil NAVON
  • GLUCOSE ANALOGS FOR DIAGNOSIS OF DISEASE STATES
    Publication number: 20180177898
    Abstract: Provided are methods and formulations for imaging at least one body region of a subject, employing a glucose analog resistant or inactive to phosphrylation, or which is not a substrate for hexokinase.
    Type: Application
    Filed: March 26, 2015
    Publication date: June 28, 2018
    Applicant: TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP
    Inventors: Gil NAVON, Michal RIVLIN, Ilan TSARFATY